Navigation Links
Lupin Receives Final Approval to Market Generic Ultram® ER
Date:8/31/2011

BALTIMORE, Aug. 31, 2011 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. (LPI) today announced that it has received final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application (ANDA) for Tramadol Hydrochloride Extended-Release Tablets, 100, 200 and 300 mg strengths.   Lupin will begin shipping its Tramadol ER shortly.

Tramadol HCl ER is a centrally acting synthetic analgesic in an extended release formulation.  It is the generic equivalent to Ortho-McNeil's Ultram®* ER Tablets and is indicated for the management of moderate to moderately severe chronic pain in adults who require around-the-clock treatment of their pain for an extended period of time.  Tramadol HCl ER tablets had annual sales of approximately $132 million for the twelve months ended June 2011 based on IMS Health sales data.

About Lupin

Headquartered in Mumbai, India, Lupin Limited is an innovation led transnational pharmaceutical company producing a wide range of quality, affordable generic and branded formulations and APIs. The Company today has significant market share in Cardiovasculars, Diabetology, Asthma, Pediatrics, CNS, GI, Anti-Infectives and NSAIDs in addition holding global leadership positions in the Anti-TB and Cephalosporins space.  

Today, Lupin is the 5th largest and fastest growing generics player in the US (by prescriptions), the only Asian company to achieve that distinction.   The company is also the fastest growing top 10 pharmaceutical player in India, Japan and South Africa. (IMS Health)

For the financial year ended March 2011, Lupin's Consolidated Revenues and Profit after Tax were Rs.57,068 million USD 1.28 Billion) and Rs. 8,626  million (USD 193 million)  respectively.  Please visit http://www.lupinworld.com for more information about Lupin Ltd.

Lupin Pharmaceuticals, Inc. is the U.S. wholly owned subsidiary of Lupin Limited.  Headquartered in Baltimore, Maryland, Lupin Pharmaceuticals, Inc. is dedicated to delivering high-quality, affordable generic medicines and branded formulations trusted by healthcare professionals and patients across geographies. For more information, visit http://www.lupinpharmaceuticals.com.

Safe Harbor Statement under the U. S. Private Securities Litigation Reform Act of 1995:

This release contains forward-looking statements that involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. Many of these risks, uncertainties and other factors include failure of clinical trials, delays in development, registration and product approvals, changes in the competitive environment, increased government control over pricing, fluctuations in the capital and foreign exchange markets and the ability to maintain patent and other intellectual property protection. The information presented in this release represents management's expectations and intentions as of this date. Lupin expressly disavows any obligation to update the information presented in this release

*Ultram® ER is a registered trademark of Ortho-McNeil-Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson.

For More Information:
Contact: Edith St-Hilaire
Director of Marketing
(410) 576-2000


'/>"/>
SOURCE Lupin Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lupin Expands Branded Play
2. Warner Chilcott Announces Settlement with Lupin of Loestrin® 24 Fe and Femcon® Fe Patent Litigations
3. HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer
4. Lupin Announces Launch of Generic Levaquin® Tablets
5. Lupin Launches Additional Strengths of Generic Lotrel® Capsules
6. Eli Lilly India and Lupin Announce Strategic Collaboration to Help Fight the Battle Against Diabetes
7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
8. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
9. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
10. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
11. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... SEATTLE , Aug. 18, 2017  Nortis today ... provide funding for the third year of a Small ... the National Institute of Neurological Disorders and Stroke (NINDS).?  ... Nortis ... ...
(Date:8/17/2017)... -- MJAC2017 , the premier cannabis event devoted to ... its leading lineup. MJAC2017 is proud ... specializing in the development of pharmaceutical and consumer products, will ... The Green Organic Dutchman are gold sponsors for the event, ... ...
(Date:8/17/2017)... CAESAREA, Israel , August 17, 2017 /PRNewswire/ ... digital health Company with mobile health and big ... securities purchase agreements with domestic and non-U.S. investors ... common stock and shares of the Company,s newly ... private placement offerings. The Company expects to conduct ...
Breaking Medicine Technology:
(Date:8/22/2017)... ... 22, 2017 , ... John Stewart joins Privis Health as ... t4 Leadership Development & Consulting. He has spent his career focusing on four ... development, servant leadership, data driven process improvement, and supportive technology. These key elements ...
(Date:8/21/2017)... ... August 22, 2017 , ... PracticeMatch, a company that provides ... employers connect with physicians and advanced practitioners like nurse practitioners and ... in August through November of this year. The online career fairs will allow job ...
(Date:8/21/2017)... ... August 21, 2017 , ... FCPX LUT Monochromatic Volume 2 is an ... easily add washed color grades to footage. A LUT is a Lookup Table that ... to the corresponding color indicated by the table. This pack comes with 60 different ...
(Date:8/21/2017)... ... 21, 2017 , ... Duncan Insurance Agency debuts the latest ... Michigan. The new initiative fundraises for the Kalamazoo Humane Society (KHS), which has ... protection and welfare by addressing the root causes of pet overpopulation. As well ...
(Date:8/21/2017)... San Diego, CA (PRWEB) , ... August 21, 2017 , ... ... Membership ( MAM ) health care reform plan, has announced his candidacy for the ... the American Dream and shared in America’s Promise. Coming to this country at age ...
Breaking Medicine News(10 mins):